Commonwealth Equity Services
IMGN

Commonwealth Equity Services’s Immunogen Inc IMGN Stock Holding History

Commonwealth Equity Services’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-23,980
Closed -$711K – 4137
2023
Q4 		$711K Sell
23,980
-1,897
-7% -$37.8K ﹤0.01% 2421
2023
Q3 		$411K Sell
25,877
-1,502
-5% -$25K ﹤0.01% 2761
2023
Q2 		$517K Sell
27,379
-151,840
-85% -$1.79M ﹤0.01% 2593
2023
Q1 		$688 Buy
179,219
+10,125
+6% +$43.2K ﹤0.01% 2293
2022
Q4 		$838K Buy
169,094
+2,409
+1% +$13.1K ﹤0.01% 2080
2022
Q3 		$796K Sell
166,685
-904
-0.5% -$4.77K ﹤0.01% 2065
2022
Q2 		$754K Buy
167,589
+137,534
+458% +$598K ﹤0.01% 2112
2022
Q1 		$143K Sell
30,055
-161
-0.5% -$891 ﹤0.01% 3411
2021
Q4 		$224K Sell
30,216
-120
-0.4% -$746 ﹤0.01% 3208
2021
Q3 		$172K Buy
30,336
+6,830
+29% +$39.5K ﹤0.01% 3322
2021
Q2 		$154K Sell
23,506
-20,580
-47% -$144K ﹤0.01% 3330
2021
Q1 		$357K Buy
44,086
+18,828
+75% +$154K ﹤0.01% 2609
2020
Q4 		$162K Sell
25,258
-466
-2% -$2.72K ﹤0.01% 2977
2020
Q3 		$92K Buy
25,724
+2,272
+10% +$9.17K ﹤0.01% 2893
2020
Q2 		$107K Sell
23,452
-22,547
-49% -$95.9K ﹤0.01% 2761
2020
Q1 		$156K Buy
45,999
+8,403
+22% +$36.7K ﹤0.01% 2472
2019
Q4 		$191K Sell
37,596
-18,488
-33% -$62.7K ﹤0.01% 2630
2019
Q3 		$135K Buy
56,084
+42,213
+304% +$112K ﹤0.01% 2633
2019
Q2 		$30K Sell
13,871
-21,858
-61% -$51.7K ﹤0.01% 2724
2019
Q1 		$96K Buy
35,729
+21,259
+147% +$92.1K ﹤0.01% 2606
2018
Q4 		$69K Sell
14,470
-643
-4% -$3.9K ﹤0.01% 2538
2018
Q3 		$143K Sell
15,113
-22
-0.1% -$211 ﹤0.01% 2587
2018
Q2 		$147K Buy
15,135
+1,149
+8% +$12.1K ﹤0.01% 2541
2018
Q1 		$147K Sell
13,986
-1,692
-11% -$16.7K ﹤0.01% 2481
2017
Q4 		$101K Buy
15,678
+89
+0.6% +$549 ﹤0.01% 2511
2017
Q3 		$119K Sell
15,589
-7,275
-32% -$48.3K ﹤0.01% 2401
2017
Q2 		$163K Buy
22,864
+7,225
+46% +$33.1K ﹤0.01% 2294
2017
Q1 		$61K Buy
15,639
+2,171
+16% +$6.34K ﹤0.01% 2310
2016
Q4 		$27K Sell
13,468
-329
-2% -$661 ﹤0.01% 2270
2016
Q3 		$37K Buy
13,797
+741
+6% +$2.15K ﹤0.01% 2181
2016
Q2 		$40K Buy
13,056
+780
+6% +$4.89K ﹤0.01% 2171
2016
Q1 		$105K Sell
12,276
-23
-0.2% -$195 ﹤0.01% 2051
2015
Q4 		$167K Hold
12,299
– – ﹤0.01% 1930
2015
Q3 		$118K Sell
12,299
-1,156
-9% -$16.9K ﹤0.01% 1961
2015
Q2 		$193K Sell
13,455
-83
-0.6% -$912 ﹤0.01% 1943
2015
Q1 		$121K Buy
13,538
+1,036
+8% +$7.5K ﹤0.01% 2029
2014
Q4 		$76K Buy
12,502
+445
+4% +$4.07K ﹤0.01% 1997
2014
Q3 		$128K Buy
12,057
+48
+0.4% +$543 ﹤0.01% 1932
2014
Q2 		$142K Sell
12,009
-29
-0.2% -$364 ﹤0.01% 1895
2014
Q1 		$180K Sell
12,038
-1,531
-11% -$24.1K ﹤0.01% 1789
2013
Q4 		$199K Sell
13,569
-4,532
-25% -$69.7K ﹤0.01% 1700
2013
Q3 		$308K Buy
18,101
+4,029
+29% +$70.8K 0.01% 1350
2013
Q2 		$233K Buy
+14,072
New +$228K ﹤0.01% 1479

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Commonwealth Equity Services's IMGN Position: Q1 2024 in Review

Commonwealth Equity Services sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 23,980 shares — an estimated $711K sold.

Commonwealth Equity Services first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $838K in Q4 2022. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Commonwealth Equity Services reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 23,980 Immunogen Inc shares in Q1 2024, an estimated $711K.
  • Commonwealth Equity Services first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Commonwealth Equity Services's Immunogen Inc position peaked at $838K in Q4 2022.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Commonwealth Equity Services's 13F filing for Q1 2024, filed 29 Apr 2024.